1800 620 420
Close menu

Past research

New drug combination turbo charges attack against cancer

Survival times have doubled in early testing of this powerful new drug combination for patients with advanced blood cancers.

Peter McCallum

Researchers identify gene that could lead to better understanding of MDS

Melbourne researchers have uncovered secrets about bone marrow failure that could enhance understanding of this rare cancer.

Carl Walkley

Novel drug for treatment of Burkitt’s lymphoma

This project hopes to identify alternative therapies for people with Burkitt’s lymphoma who do not respond to standard treatment or relapse.

Andreas Strasser and Gemma Kelly

Unlocking leukaemia’s genetic secrets

Therese Vu is investigating the role of a gene that may play a role in transforming a blood disorder into acute myeloid leukaemia.

Therese Vu

Boosting the immune system response

Dr Stephen Mattarollo is investigating how a new vaccine, combined with front-line therapy, Rituximab, improves outcomes for non-Hodgkin lymphoma patients.

Dr Stephen Mattarollo

Graft v Host disease

To help better understand cGVHD, Katie Lineburg is investigating the cellular processes and immune cells involved in driving the disease.

Katie Lineburg

Targeting stem cells in myeloproliferative disorders

Dr Steven Lane is evaluating a new combination drug therapy for polycythemia vera (PRV).

Steven Lane in the office

Double discovery – game changer in quest to cure leukaemia

Researchers at the Peter MacCallum Cancer Centre (Melbourne) have uncovered vital new leads on how to outsmart the deadly disease.

Mark Dawson

Research project archive

An archive of the blood cancer research projects we’ve funded since 2008.

Dr Karthik Nath